Interleukin 3 and interleukin 3/gm‐csf combination therapy ‐ clinical implications

This publication has 22 references indexed in Scilit:

• Peripheral blood progenitor cells mobilized by chemotherapy plus granulocyte-colony stimulating factor accelerate both neutrophil and platelet recovery after high-dose VP16, ifosfamide and cisplatin
  British Journal of Haematology, 1993
• Recombinant human interleukin 3 in clinical oncology
  The International Journal of Cell Cloning, 1993
• Effect of Interleukin-3 on Responsiveness to Granulocyte-Colony-stimulating Factor in Severe Aplastic Anemia
  Annals of Internal Medicine, 1992
• Acute-phase response in patients given rhIL-3 after chemotherapy
  The Lancet, 1992
• Sequential in vivo treatment with two recombinant human hematopoietic growth factors (interleukin-3 and granulocyte-macrophage colony- stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: results of a phase I study
  Blood, 1992
• Recombinant human interleukin-3 and recombinant human granulocyte- macrophage colony-stimulating factor administered in vivo after high- dose cyclophosphamide cancer chemotherapy: effect on hematopoiesis and microenvironment in human bone marrow
  Blood, 1992
• Treatment of Diamond‐Blackfan anaemia with haematopoietic growth factors, granulocyte‐macrophage colony stimulating factor and interleukin 3: sustained remissions following IL‐3
  British Journal of Haematology, 1991
• Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein.
  Proceedings of the National Academy of Sciences, 1991
• Stimulation of Pancreas and Gastric Carcinoma Cell Growth by Interleukin 3 and Granulocyte-Macrophage Colony—Stimulating Factor
  Gastroenterology, 1991
• Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine.
  Proceedings of the National Academy of Sciences, 1990